Smith Edward F 4
4 · MARINUS PHARMACEUTICALS INC · Filed Mar 11, 2021
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2021-03-09$4.16/sh+35,927$149,456→ 53,644 total - Sale
Common Stock
2021-03-09$17.80/sh−40,356$718,337→ 13,288 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-09−35,927→ 0 totalExercise: $4.16Exp: 2023-11-25→ Common Stock (35,927 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2020.
- [F2]The option was fully vested as of November 25, 2017.